These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28120548)

  • 1. DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug.
    Singh K; Shekhar S; Yadav Y; Xess I; Dey S
    J Pept Sci; 2017 Mar; 23(3):228-235. PubMed ID: 28120548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical
    Chen YC; Chen FJ; Lee CH
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33252326
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
    Kawai A; Yamagishi Y; Mikamo H
    J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
    Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
    J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of spider venom-derived peptide lycosin-I against Candida tropicalis.
    Tan L; Bai L; Wang L; He L; Li G; Du W; Shen T; Xiang Z; Wu J; Liu Z; Hu M
    Microbiol Res; 2018 Nov; 216():120-128. PubMed ID: 30269852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.
    Vipulanandan G; Herrera M; Wiederhold NP; Li X; Mintz J; Wickes BL; Kadosh D
    J Dent Res; 2018 Jan; 97(1):91-98. PubMed ID: 28850289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
    Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Antifungal Activity of Chitosan with Fluconazole against
    Lo WH; Deng FS; Chang CJ; Lin CH
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33153228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.
    Al-Fattani MA; Douglas LJ
    J Med Microbiol; 2006 Aug; 55(Pt 8):999-1008. PubMed ID: 16849719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dispersal of single and mixed non-albicans Candida species biofilms by β-1,3-glucanase in vitro.
    Tan Y; Leonhard M; Ma S; Moser D; Schneider-Stickler B
    Microb Pathog; 2017 Dec; 113():342-347. PubMed ID: 29101060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users.
    Shanmughapriya S; Sornakumari H; Lency A; Kavitha S; Natarajaseenivasan K
    Med Mycol; 2014 Nov; 52(8):853-61. PubMed ID: 25202127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida tropicalis biofilm inhibition by ZnO nanoparticles and EDTA.
    Jothiprakasam V; Sambantham M; Chinnathambi S; Vijayaboopathi S
    Arch Oral Biol; 2017 Jan; 73():21-24. PubMed ID: 27653145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-Lapse Tracking of Candida tropicalis Biofilm Formation and the Antifungal Efficacy of Liposomal Amphotericin B.
    Kawai A; Yamagishi Y; Mikamo H
    Jpn J Infect Dis; 2017 Sep; 70(5):559-564. PubMed ID: 28674314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
    Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.